Stockwatch Street Wires
- Shell Summary for Jan. 21, 2020
Mitchell Smith's capital pool shell, Sceptre Ventures, plans to acquire Izon Network, a digital advertising firm that has been trying to go public in Canada since 2008. Izon Network trades on the pink sheets and last closed at 1.8 U.S. cents.
- Cannabis Summary for Jan. 21, 2020
Harvest Health's failed acquisition target, Falcon International, says Harvest owes Falcon $50-million for a breakup fee. Harvest filed a suit against Falcon two weeks ago. Tetra falls after arranging a $10-million financing. Centr gets its CBD beverages in Texas 7-11s.
- Energy Summary for Jan. 21, 2020
Enerplus fails to impress investors with cautious 2020 guidance. Baytex Energy boasts of better-than-expected 2019 production and refinances some of its debt. Canacol Energy keeps busy in Colombia, and Centaurus Energy mulls the future of Curamhuele.
- IIROC fines De Cicco $60,000 over unsuitable trades
IIROC has fined Scotia Capital Inc. employee Lelio De Cicco $60,000 after he allowed high-risk trades in the account of a 90-year-old B.C. woman. The woman was in a care home, and her son had authority for the account.
- Gold Summary for Jan. 21, 2020
B2Gold has a new PEA at its Gramalote gold project in Colombia. This time, a feasibility study is still in the cards. Wallbridge Mining has new assays from Fenelon, including high-grade encouragement at Area 51. Drilling will continue for much of the year.
- Diamond & Specialty Minerals Summary for Jan. 21, 2020
Olivut Resources mulls its Seahorse options while Talmora Diamond waits. Cruz Cobalt has raised a bit of cash to bolster its working capital. Montero Mining and Exploration threatens Tanzania with arbitration over their Wigu Hill dispute.
- Shell Summary for Jan. 20, 2020
Robert Kiesman's first capital pool shell, Libby K Industries, plans to acquire Plurilock Security Solutions, a cybersecurity firm in Victoria. Libby and Plurilock aim to raise $4-million. Plurilock is selling shares at 18.75 cents, as well as debentures.
- Cannabis Summary for Jan. 20, 2020
Rubicon receives its first orders from B.C. and Saskatchewan for its Simply Bare marijuana brand. True Leafs points to a mistaken reference to the company and its trading symbol to explain the recent increase in its share price. Ignite talks plans for a new beverage line.
- Energy Summary for Jan. 20, 2020
Granite Oil accepts a 95-cent-a-share offer from the acquisitive International Petroleum. Paramount Resources and Pipestone Energy eye a plant outage in the Montney. Touchstone Exploration and Africa Energy hype their far-flung exploration programs.
- Gold Summary for Jan. 20, 2020
Marathon Gold has revised its resource estimate for the Valentine Lake gold project with a prefeasibility study in mind. Nighthawk Gold has new assays from Colomac that offered geological encouragement, but which left investors unenthused.
- Diamond & Specialty Minerals Summary for Jan. 20, 2020
RJK Exploration is pressing ahead with its hunt for Timiskaming kimberlites. Voyageur Pharmaceuticals is working on a dream sheet for Frances Lake, its barium project in B.C. Gratomic continues to seek, and occasionally finds, new cash for Aukam.
- Valens Groworks sued over $500,000 finder's fee
Valens Groworks Corp. is a defendant in a lawsuit over an unpaid $500,000 finder's fee. The fee stems from the company's $11-million sale of Supra THC Services Inc. in 2018.
- Shell Summary for Jan. 17, 2020
Neil Currie's first capital pool shell,
First Light Capital, arranges a tech QT with vMobo Inc. This target must sell $5-million worth of units at 55 cents and $1.2-million (U.S.) worth of debentures.
- Energy Summary for Jan. 17, 2020
The UN committee that castigated Coastal GasLink cops to knowing next to nothing about Coastal GasLink. EnCana hears of its imminent removal from the S&P/TSX. Obsidian Energy talks up the Alberta Cardium, and Crew Energy touts "strategic" debt deals.
- Cannabis Summary for Jan. 17, 2020
Canopy Growth delays the release of its cannabis-infused beverages for an unspecified period. Tetra Bio rises after receiving two drug identification numbers (DIN) for an OTC hemorrhoid drug and a back and muscle pain drug. Hexo arranges a $20-million (U.S.) financing.
Click here for more Street Wires.